SDC2

Syndecan-2 · P34741 · SDC2 on Sugi Atlas →

4,036 patent compounds predicted against SDC2, 1,539 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL2179112 SCHEMBL2179112 0.52 9/20
SCHEMBL2181199 SCHEMBL2181199 0.76 8/20
SCHEMBL2177896 SCHEMBL2177896 0.65 8/20
SCHEMBL2177628 SCHEMBL2177628 0.61 8/20
SCHEMBL1500322 SCHEMBL1500322 0.59 8/20
SCHEMBL2180951 SCHEMBL2180951 0.56 8/20
SCHEMBL2180875 SCHEMBL2180875 0.51 8/20
SCHEMBL7063991 SCHEMBL7063991 0.49 8/20
SCHEMBL7063999 SCHEMBL7063999 0.49 8/20
SCHEMBL2181074 SCHEMBL2181074 0.63 7/20
SCHEMBL7415929 SCHEMBL7415929 0.60 7/20
SCHEMBL7415930 SCHEMBL7415930 0.60 7/20
SCHEMBL1500260 SCHEMBL1500260 0.58 7/20
SCHEMBL1500172 SCHEMBL1500172 0.55 7/20
SCHEMBL7064833 SCHEMBL7064833 0.47 7/20
SCHEMBL7064840 SCHEMBL7064840 0.47 7/20
SCHEMBL1500196 SCHEMBL1500196 0.57 6/20
SCHEMBL2176682 SCHEMBL2176682 0.56 6/20
SCHEMBL2176688 SCHEMBL2176688 0.56 6/20
SCHEMBL8141859 SCHEMBL8141859 0.55 6/20

Clinical trials — most relevant to SDC2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of Dexmedetomidine and Total Intravenous Anesthesia on Endothelial Damage-Related Biomarkers PHASE4COMPLETED
Volume Kinetics for Hyperoncotic Albumin in Burn Patients as Well as for Healthy Subjects PHASE4COMPLETED
Intratumoral Injection of Autologous CD1c (BDCA-1)+ MyDC, Avelumab, and Ipilimumab Plus Systemic Nivolumab PHASE1/PHASE2RECRUITING
The Synapse Project PHASE2COMPLETED
Study of Protection And Repair of Endothelial-glycocalyx in Sepsis (SPARES) PHASE2NOT_YET_RECRUITING
CD19 and CD22 Dual-targeted CAR-T Cells for Relapsed or Refractory B-NHL EARLY_PHASE1UNKNOWN
Syndecan-1 a Surrogate Marker for IBD nanCOMPLETED
Evaluation of Endothelial Glycocalyx in the Surgical Resuscitation of Major Burn Patients nanRECRUITING
The Glycocalyx in COVID-19 Patients. A Pilot Study nanCOMPLETED
Early Diagnosis and Prognosis of Postoperative Sepsis by Presepsin and Syndecan-1 nanUNKNOWN
Myoglobin Removal With CytoSorb in Rhabdomyolysis nanCOMPLETED
VASCULUX-examination of the Pulmonary VASCUlar Barrier in Patients During LUng Transplantation nanUNKNOWN
Cardiogenic Shock Integrated PHenotyping for Event Reduction nanRECRUITING
Perioperative Plasma Levels of Glycocalyx Markers in Colon Surgery. nanUNKNOWN
The FGF/FGFR Signalling Pathway: nanCOMPLETED
Comparative Analysis of Gremlin-1, Syndecan-4 and IL-1 Beta Levels in Gingival Crevicular Fluid Among İndividuals With Periodontal Health and Stage III Periodontitis, Considering Both Smokers and Non-Smokers, Before and After Non-Surgical Periodontal Therapy nanACTIVE_NOT_RECRUITING
Comparison of Liberal and Restrictive Fluid Management on the Endothelial Glycocalyx in Radical Cystectomy nanCOMPLETED
Syndecan-4 as a Biomarker in Patients With Chagas Disease nanCOMPLETED
Comparison of the Effects of Sevoflurane and Desflurane on Endothelial Glycocalyx nanCOMPLETED
The Effect of Anesthetics Agents on Vascular Injury and Level of Syndecan-1 During Knee Surgery nanCOMPLETED
Genetic Identification (ID) of Segmental Dysplastic Nevi nanWITHDRAWN
COronary Microcirculation and Troponin Elevation in Septic Shock nanCOMPLETED
Clinically Actionable Tumor-Associated Antigens in Prostate Cancer nanACTIVE_NOT_RECRUITING
Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient nanRECRUITING
Alpha-lipoic Acid in Critically Ill Patients With Sepsis nanCOMPLETED
Randomized Trial of Fresh Frozen Plasma Versus Albumin in Acute Burn Resuscitation nanCOMPLETED
Descriptive Analysis of Surgeries in Patients With Multiple Osteochondromas nanRECRUITING
Natural History Study of Children With LAMA2-related Dystrophies nanRECRUITING
Biomarkers of Lichen Sclerosus nanUNKNOWN
Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SDC2 binder may also engage these)

ProteinNameSimilarity
Q58DD4 1.000 Q58DD4 →
Q6GR51 1.000 Q6GR51 →
P34900 1.000 P34900 →
P43407 1.000 P43407 →
Q5RAT9 1.000 Q5RAT9 →
P49414 0.998 P49414 →
SDC4 Syndecan-4 (SYND4) (Amphiglycan) (Ryudocan co 0.997 landscape →
P50605 0.997 P50605 →
P34901 0.996 P34901 →
Q8HZJ6 0.994 Q8HZJ6 →
P49416 0.993 P49416 →
O35988 0.991 O35988 →
B1H3G4 0.990 B1H3G4 →
Q5RE35 0.990 Q5RE35 →
AREG Amphiregulin 0.989 landscape →
Q1AGV6 0.989 Q1AGV6 →
P31955 0.989 P31955 →
Q9Y5Y7 0.989 Q9Y5Y7 →
P26261 0.987 P26261 →
A1A4K1 0.987 A1A4K1 →
Q95M19 0.987 Q95M19 →
Q9DC11 0.986 Q9DC11 →
Q9BZD6 0.986 Q9BZD6 →
A6QP06 0.986 A6QP06 →
Q14CH0 0.986 Q14CH0 →
Q10651 0.986 Q10651 →
Q8R1R5 0.985 Q8R1R5 →
P14221 0.985 P14221 →
Q6P995 0.985 Q6P995 →
P24338 0.985 P24338 →